Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
27.4M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
6.52M
-
Shares change
-
+1.61M
-
Total reported value, excl. options
-
$47.9M
-
Value change
-
+$11.6M
-
Put/Call ratio
-
0.78
-
Number of buys
-
47
-
Number of sells
-
-21
-
Price
-
$7.34
Significant Holders of ICAD, INC. - Common Stock, $0.01 par value (ICAD) as of Q1 2020
85 filings reported holding ICAD - ICAD, INC. - Common Stock, $0.01 par value as of Q1 2020.
ICAD, INC. - Common Stock, $0.01 par value (ICAD) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.52M shares
of 27.4M outstanding shares and own 23.8% of the company stock.
Largest 10 shareholders include Parkman Healthcare Partners LLC (726K shares), RENAISSANCE TECHNOLOGIES LLC (660K shares), G2 Investment Partners Management LLC (614K shares), EAM Investors, LLC (511K shares), BlackRock Inc. (409K shares), Fairpointe Capital LLC (350K shares), EAM Global Investors LLC (246K shares), Manatuck Hill Partners, LLC (210K shares), MILLENNIUM MANAGEMENT LLC (206K shares), and WELLINGTON MANAGEMENT GROUP LLP (204K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.